Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 53.18M | -4.20%180.62M | 45.94M | 40.63M | 52.67%188.54M | 49.02%123.49M | 18.63%82.87M | 69.86M |
| Cost of revenue | 46.59M | -5.29%153.36M | 38.41M | 34.48M | 51.70%161.93M | 41.85%106.75M | 31.71%75.25M | 57.13M |
| Gross profit | 6.6M | 2.43%27.26M | 7.53M | 6.15M | 58.89%26.61M | 119.79%16.75M | -40.12%7.62M | 12.72M |
| Operating expense | 2.22M | 13.87%8.78M | 2.84M | 2.43M | 21.54%7.71M | 27.99%6.35M | 42.79%4.96M | 3.47M |
| Staff costs | ---- | ---- | ---- | ---- | 12.75%5.06M | 36.60%4.49M | 19.72%3.28M | --2.74M |
| Selling and administrative expenses | --2.2M | 15.73%9.87M | --3.47M | --2.6M | 751.02%8.53M | -34.64%1M | 400.98%1.53M | --306K |
| -General and administrative expense | --2.2M | 15.73%9.87M | --3.47M | --2.6M | 751.02%8.53M | -34.64%1M | 400.98%1.53M | --306K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | 54.14%652K | 71.95%423K | -26.35%246K | --334K |
| -Depreciation | ---- | ---- | ---- | ---- | 54.14%652K | 71.95%423K | -26.35%246K | --334K |
| Other operating expenses | --183K | 5.05%64K | ---- | ---- | -90.75%60.93K | 39.62%659K | 86.56%472K | --253K |
| Total other operating income | --160K | 31.47%1.15M | --636K | --166K | 291.95%874.04K | -61.28%223K | 253.37%576K | --163K |
| Operating profit | 4.38M | -2.23%18.47M | 4.69M | 3.71M | 81.69%18.9M | 290.90%10.4M | -71.24%2.66M | 9.25M |
| Net non-operating interest income (expenses) | -786K | -18.91%-3.34M | -826K | -848K | -88.92%-2.81M | -96.83%-1.48M | 15.42%-754.33K | -891.88K |
| Non-operating interest expense | --786K | 18.91%3.34M | --826K | --848K | 88.92%2.81M | 96.83%1.48M | -15.42%754.33K | --891.88K |
| Net investment income | 3,471.30%3.86M | 108K | ||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||
| Income from associates and other participating interests | 98.96%-4.22K | -255.11%-405.46K | -55.57%261.4K | 47.73%588.36K | 398.27K | |||
| Special income (charges) | 99.01%-4K | 82K | 67K | -116.25%-405K | 103.64%2.49M | 21.65%1.22M | 1.01M | |
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | --61K | --0 | --0 | --10K |
| Less:Other special charges | ---- | ---- | ---- | ---- | 73.86%-649K | -223.73%-2.48M | 20.76%-767K | ---968K |
| Less:Write off | ---- | -99.01%4K | ---82K | ---67K | 4,710.13%405K | 98.08%-8.79K | -855.03%-456.62K | ---47.81K |
| Other non-operating income (expenses) | 280.00%19K | -96.88%5K | -23.08%160K | 208K | ||||
| Income before tax | 3.59M | -3.51%15.13M | 3.95M | 2.93M | 34.36%15.68M | 50.86%11.67M | -23.22%7.74M | 10.08M |
| Income tax | 887K | 9.48%4.77M | 1.6M | 805K | 48.63%4.36M | 299.55%2.93M | -68.13%734.33K | 2.3M |
| Net income | 2.7M | -8.52%10.36M | 2.35M | 2.13M | 29.57%11.32M | 24.79%8.74M | -9.92%7M | 7.77M |
| Net income continuous operations | --2.7M | -8.52%10.36M | --2.35M | --2.13M | 29.57%11.32M | 24.79%8.74M | -9.92%7M | --7.77M |
| Noncontrolling interests | ||||||||
| Net income attributable to the company | 2.7M | -8.52%10.36M | 2.35M | 2.13M | 29.57%11.32M | 24.79%8.74M | -9.92%7M | 7.77M |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.7M | -8.52%10.36M | 2.35M | 2.13M | 29.57%11.32M | 24.79%8.74M | -9.92%7M | 7.77M |
| Gross dividend payment | ||||||||
| Basic earnings per share | 0.005 | 73.62%0.0364 | 0.0043 | 0.0039 | 29.57%0.021 | 24.79%0.0162 | -9.91%0.013 | 0.0144 |
| Diluted earnings per share | 0.005 | 73.62%0.0364 | 0.0043 | 0.0039 | 29.57%0.021 | 24.79%0.0162 | -9.91%0.013 | 0.0144 |
| Dividend per share | ||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.